A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer

Research output: Contribution to journalArticleScientificpeer-review

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)59-67
JournalCancer Chemother Pharmacol
Volume66
Issue number1
DOIs
Publication statusPublished - 2010
Publication typeA1 Journal article-refereed

Cite this